stannic oxide has been researched along with Pulmonary Alveolar Proteinosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y; Liu, N; Ma, Z; Wang, Y; Yao, S; Zhou, C | 1 |
| Guan, Y; Li, G; Liu, N; Ma, Z; Wang, R; Yao, S; Zhao, L | 1 |
2 other study(ies) available for stannic oxide and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
Pulmonary and Systemic Toxicity in a Rat Model of Pulmonary Alveolar Proteinosis Induced by Indium-Tin Oxide Nanoparticles.
Topics: Animals; Indium; Lung; Male; Nanoparticles; Pulmonary Alveolar Proteinosis; Rats; Tin Compounds; Tissue Distribution | 2022 |
N-acetylcysteine alleviates pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles in male rats: involvement of the NF-κB signaling pathway.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Indium; Lung; Lung Injury; Male; Nanoparticles; NF-kappa B; Pulmonary Alveolar Proteinosis; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Tin Compounds; Tumor Necrosis Factor-alpha | 2022 |